Am I eligible for the program?
You may be eligible for our free prescription program if you meet the requirements below:
- You have been prescribed a Johnson & Johnson operating company donated medication
- You meet the eligibility income requirements for the medication(s). You may view the income requirements below
- You don’t have insurance or medicine is not covered
- Some patients with Medicare Prescription Drug Coverage (Part D) who cannot afford their medicines and who meet certain financial criteria may also be eligible for assistance
- A report from your pharmacy or an Explanation of Benefits (EOB) statement from your insurer that shows your out-of-pocket costs for the current year can be requested and may be submitted with your application. In order to qualify for the program, you must spend 4% or more of your gross annual income on prescription drugs.
- You live in the United States or a U.S. Territory
- You are being treated by a U.S. licensed doctor as an outpatient
BALVERSA®
(erdafitinib) Tablets
DARZALEX®
(daratumumab) Injection for intravenous infusion
DARZALEX FASPRO®
(daratumumab and hyaluronidase-fihj), injection for subcutaneous use
EDURANT® 1
(rilpivirine) Tablets
ELMIRON®
(pentosan polysulfate sodium) Capsules
ERLEADA®
(apalutamide) Tablets
HALDOL® Decanoate†
(haloperidol) IM Injection Only
IMBRUVICA®
(ibrutinib) Capsules/Tablets
INTELENCE® 1
(etravirine) Tablets
INVEGA HAFYERA™ †
(paliperidone palmitate) Extended-Release Injectable Suspension
INVEGA SUSTENNA® †
(paliperidone palmitate) Extended-Release Injectable Suspension
INVEGA TRINZA®†
(paliperidone palmitate) Extended-Release Injectable Suspension
INVOKAMET®† 1
(canagliflozin/metformin HCI) Tablets
INVOKAMET® XR† 1
(canagliflozin/metformin HCI) Tablets
INVOKANA®1
(canagliflozin) Tablets
MONOVISC®
(high molecular weight hyaluronan) Injection
ORTHOVISC®
(high molecular weight hyaluronan) Injection
PONVORY™
(ponesimod) Tablets
PREZCOBIX®1
(darunavir 800mg/cobicistat 150mg) Tablets
PREZISTA® 1
(darunavir) Tablets/Oral Suspension
PROCRIT® †
(epoetin alfa) Injection
REMICADE® †
(infliximab) IV Infusion
RISPERDAL CONSTA® †
(risperidone) Long-Acting Injection
RYBREVANT®
(amivantamab-vmjw) Injection
SIMPONI® †
(golimumab) Injection
SIMPONI ARIA®†
(golimumab) IV Infusion
SIRTURO® †
(bedaquiline) Tablets
SPORANOX® †
(itraconazole) Capsules
SPORANOX® †
(itraconazole) Oral Solution
SPRAVATO® †
(esketamine) Nasal Spray, for intranasal use, CIII
STELARA®
(ustekinumab) Injection, for subcutaneous or intravenous use
SYMTUZA® †
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets
TREMFYA®
(guselkumab) Injection, for subcutaneous use
XARELTO® † 1
(rivaroxaban) Tablets or Oral Suspension
YONDELIS®
(trabectedin) Injection for intravenous infusion
ZYTIGA®
(abiraterone acetate) Tablets